Additional information
| Active substance | Exemestane | 
|---|---|
| Active Half-Life | 9 hours | 
| Classification | Steroidal aromatase inhibitor | 
| Dosage | 12.5-25 mg/day | 
| Acne | No | 
| Water Retention | No | 
| HBR | No | 
| Hepatotoxicity | No | 
| Aromatization | No | 
| Lab Test | Monitors estrogen levels and liver function | 
| Also known as | Exemestane | 
| WAREHOUSE | International Warehouse 2 | 
| Blood pressure | Can potentially increase blood pressure | 
| Trade name | Aromasin | 
| Storage conditions | Store at room temperature away from moisture and heat | 
| Chemical name | 6-Methylideneandrosta-1,4-diene-3,17-dione | 
| Formula | C20H24O2 | 
| Substance class | Aromatase inhibitor | 
| Main action | Inhibits aromatase enzyme, reducing estrogen synthesis | 
| Half-life | 27 hours | 
| Dosage (medical) | 25 mg once daily | 
| Dosage (sports) | 12.5 to 25 mg once daily | 
| Effects | Decreases circulating estrogen levels, increases testosterone levels | 
| Side effects | Hot flashes, headache, fatigue, increased sweating, joint pain | 
| Use in sports | Used to prevent estrogen-related side effects and water retention in anabolic steroid users | 
| Manufacturer | Pfizer | 
 PROMIFEN ALPHA PHARMA
							PROMIFEN ALPHA PHARMA						 Nolvadex 20 SINGANI PHARMA
							Nolvadex 20 SINGANI PHARMA						 LETROROW cRowX Labs
							LETROROW cRowX Labs						 AROMASIN NORDIC FUSION
							AROMASIN NORDIC FUSION						

 
			 
			 
			 
			
Reviews
There are no reviews yet.